The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12560
StudyName: Eligibility Active, Moderate to Severe Rheumatoid Arthritis NCT00642629
Date of export from the portal: 02.07.2020
Date of Upload / last change: 30.11.2015
License: Creative Commons BY 4.0

----

Description: 
A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT00642629
